Mammalian target of rapamycin inhibition impacts energy homeostasis and induces sex‐specific body weight loss in humans

Mechanisms of myostatin and activin A accumulation in chronic kidney disease

(2022) Stanislas Bataille et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Efficacy and Safety of a Long-Term Multidisciplinary Weight Loss Intervention under Hospitalization in Aging Patients with Obesity: An Open Label Study

(2022) Hanan Abbas et al.   Nutrients

Intermittent fasting and protein pacing are superior to caloric restriction for weight and visceral fat loss

(2022) Paul J. Arciero et al.   Obesity

Very-low-protein diets lead to reduced food intake and weight loss, linked to inhibition of hypothalamic mTOR signaling, in mice

(2021) Yingga Wu et al.   Cell Metabolism

Fibroblast Primary Cilia are Required for Cardiac Fibrosis

(2019) Elisa Villalobos et al.   CIRCULATION

Kidney cachexia or protein‐energy wasting in chronic kidney disease: facts and numbers

(2019) Laetitia Koppe et al.   Journal of Cachexia Sarcopenia and Muscle

Cachexia/Protein energy wasting syndrome in CKD: Causation and treatment

(2019) Eduardo A. Oliveira et al.   SEMINARS IN DIALYSIS

Frailty, physical function and affective status in elderly patients on hemodialysis

(2019) Aurora López-Montes et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Sex differences in macronutrient intake and adherence to dietary recommendations: findings from the UK Biobank

(2018) Elizabeth Bennett et al.   BMJ Open

Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial

(2015) Anja Mähler et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

17ß-Estradiol Regulates mTORC2 Sensitivity to Rapamycin in Adaptive Cardiac Remodeling

(2015) Angelika Kusch et al.   PLoS One

Elevated expression of activins promotes muscle wasting and cachexia

(2013) Justin L. Chen et al.   FASEB JOURNAL

Sex-Specific mTOR Signaling Determines Sexual Dimorphism in Myocardial Adaptation in Normotensive DOCA-Salt Model

(2013) Dennis Gürgen et al.   HYPERTENSION

mTOR and regulation of energy homeostasis in humans

(2013) Marwan Mannaa et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies

(2012) Toshio Mochizuki et al.   Clinical and Experimental Nephrology

Aliskiren penetrates adipose and skeletal muscle tissue and reduces renin–angiotensin system activity in obese hypertensive patients

(2012) Michael Boschmann et al.   JOURNAL OF HYPERTENSION

Wasting in chronic kidney disease

(2011) Robert H. Mak et al.   Journal of Cachexia Sarcopenia and Muscle

Luteinizing Hormone Stimulates Mammalian Target of Rapamycin Signaling in Bovine Luteal Cells via Pathways Independent of AKT and Mitogen-Activated Protein Kinase: Modulation of Glycogen Synthase Kinase 3 and AMP-Activated Protein Kinase

(2010) Xiaoying Hou et al.   ENDOCRINOLOGY

LMNAMutations, Skeletal Muscle Lipid Metabolism, and Insulin Resistance

(2010) Michael Boschmann et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

mTOR: from growth signal integration to cancer, diabetes and ageing

(2010) Roberto Zoncu et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease

(2010) Gerd Walz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Autosomal Dominant Polycystic Kidney Disease

(2008) Jared J. Grantham   NEW ENGLAND JOURNAL OF MEDICINE

Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients

(2008) Jordi Rovira et al.   TRANSPLANT INTERNATIONAL